Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment

Journal of Biomedical Nanotechnology

Volumn 9, Issue 12, 2013, Pages 2105-2116

  Elbialy, Nihal S ^a   Abdol Azim, Bahaa Mostafa ^a   Shafaa, Medhat W ^b   El Shazly, Laila H ^c   El Shazly, Amany H ^d   Khalil, Wafaa A ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b Helwan University   (Egypt)

^c General Organization for Teaching Hospitals and Institutes   (Egypt)

^d RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

Entrapment efficiency; Liposomes; Prednisolone acetate; Release rate; Transcorneal flux; Uveitis

Indexed keywords

ENTRAPMENT EFFICIENCY; PREDNISOLONE; RELEASE RATE; TRANSCORNEAL; UVEITIS;

DRUG DELIVERY; EFFICIENCY; OPHTHALMOLOGY; SIZE DETERMINATION; VOLATILE FATTY ACIDS;

LIPOSOMES;

LIPOSOME; PREDNISOLONE ACETATE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALE; NONHUMAN; SURFACE CHARGE; UVEITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG SYNERGISM; EYE; EYE DISEASES; INSTILLATION, DRUG; LIPOSOMES; MALE; OPHTHALMIC SOLUTIONS; PREDNISOLONE; RABBITS; UVEITIS, ANTERIOR;

EID: 84888785305     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1711     Document Type: Article

References (43)

1. I. P. Kaur, A. Garg, A. K. Singla, and D. Aggarwal, Vesicular systems in ocular drug delivery: An overview. Int. J. Pharm. 269, 1 (2004).
2. G. P. Mishra, M. Bagui, V. Tamboli, and A. K. Mitra, Recent applications of liposomes in ophthalmic drug delivery. J. Drug. Deliv. 2011, 1 (2011).
3. S. Kawakami, K. Yamamura, T. Mukai, K. Nishida, J. Nakamura, T. Sakaeda, M. Nakashima, and H. Sasaki, Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes. J. Pharm. Pharmacol. 53, 1157 (2001).
4. J. Araújo, E. Gonzalez, M. A. Egea, M. L. Garcia, and E. B. Souto, Nanomedicines for ocular NSAIDs: Safety on drug delivery. Nanomedicine: Nanotechnology Biology, and Medicine 5, 394 (2009).
5. S. Ebrahim, G. A. Peyman, and P. J. Lee, Applications of liposomes in ophthalmology. Surv. Ophthalmol. 50, 167 (2005).
6. M. W. Shafaa, N. M. Sabra, and R. A. Fouad, The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits. Biopharm. Drug. Dispos. 32, 507 (2011).
7. O. N. El-Gazayerly, O. H. El-Nesr, and S. A. Yahiya, Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes. Saudi. Pharm. J. 18, 217 (2010).
8. P. Chetoni, S. Rossi, S. Burgalassi, D. Monti, S. Mariotti, and F. Saettone, Comparison of liposome-encapsulated acyclovir with acyclovir ointment: Ocular pharmacokinetics in rabbits. J. Ocul. Pharmacol. Ther. 20, 169 (2004).
9. A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238 (1965).
10. R. Cortesi, R. Argnani, and E. Esposito, Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int. J. Pharm. 317, 90 (2006).
11. J. M. Leong, Y. C. Chung, and J. H. Hwan, Enhanced adjuvantic property of polymerized liposome as compared to a phospholipid liposome. J. Biotechnol. 94, 255 (2002).
12. S. Benita, D. Friedamn, and M. Weinstock, Pharmacological evaluation of an injectable prolonged release emulsion of physostigmine in rabbits. J. Pharm. Pharmacol. 38, 653 (1986).
13. S. L Law, K. Huang, and C. Chiang, Acyclovir-containing liposomes for potential ocular delivery: Corneal penetration and absorption. J. Control. Release 63, 135 (2000).
14. N. L. Burstein and J. A. Anderdon, Review: Corneal penetration and ocular bioavailability of drugs. J. Ocul. Pharmacol. 1, 309 (1985).
15. K. Jarvinen, T. Jarvinen, and A. Urttia, Ocular absorption following topical delivery. Adv. Drug. Deliver. Rev. 16, 3 (1995).
16. R. D. Schoenwald and H. S. Huang, Corneal penetration behavior of b-blocking agents. I. Physicochemical factors. J. Pharm. Sci. 72, 1266 (1983).
17. S. AbuRuza and J. Millership, Simple liquid chromatography method for the rapid simultaneous determination of prednisolone and cortisol in plasma and urine using hydrophilic lipophilic balanced solid phase extraction cartridges. J. Chromatogr. B 798, 193 (2003).
18. J. Howes, H. Baru, and N. Ron, Loteprednol etabonate comparison with other steroids in two models of intraocular inflammation. J. Ocul. Pharmacol. 10, 289 (1994).
19. J. L. Bellot, M. Palmero, C. Garcia-Cabanes, R. Espi, C. Hariton, and A. Orts, Additive effect of nitric oxide and PGE2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm. Res. 45, 203 (1996).
20. D. Paolino, M. Fresta, P. Sinha, and M. Ferrari, Encyclipedia of Medical Devices and Instrumentation, 2nd edn., edited by J. G. Webster, John Wiley & Sons, New York (2006), Vol. 6, pp. 437-495.
21. D. G. Fatouros, K. Hatzidimitriou, and S. G. Antimisiaris, Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: Comparison of membrane integrity and drug release. Eur. J. Pharm. Sci. 13, 287 (2001).
22. M. Gulati, M. Grover, S. Singh, and M. Singh, Lipophilic drug derivatives in liposomes. Int. J. Pharm. 165, 129 (1998).
23. L. Zeng and X. Wu, Modeling the sustained release of lipophilic drugs from liposomes. Appl. Phys. Lett. 97, 1 (2010).
24. D. Papahadjopoulos, K. Jacobson, S. Nir, and T. Isac, Phase transition in phospholipid vesicles: Fluorescence polarization and permeability measurements conceraing the effect of temperature and cholesterol. Biochim. Biophy. Acta. 31, 330 (1973).
25. O. H. Alpar, J. B. Bamford, and V. Walters, The in vitro incorporation and release of hydroxocobalamin by liposomes. Int. J. Pharm. 7, 349 (1981).
26. G. V. Betageri and D. L. Parsons, Drug encapsulation and release from multilamellar and unilamcllar liposomes. Int. J. Pharm. 81, 235 (1992).
27. R. M. Hathout, S. Mansour, N. D. Mortada, and A. S. Guinedi, Liposomes as an ocular delivery system for acetazolamide: In vitro and in vivo studies. AAPS. Pharm. Sci. Tech. 8, 1 (2007).
28. G. M. Grass and J. R. Robinson, Mechanisms of cornea1 drug penetration II: Ultrastructural analysis of potential pathways for drug movement. J. Pharm. Sci. 77, 15 (1988).
29. K. Singh and M. Mezei, Liposomal ophthalmic drug delivery system II. Dihydrostreptomycin sulfate. Inf. J. Pharm. 19, 263 (1984).
30. U. Pleyer, J. Grammer, P. Kosmidis, and D. G. Ruckert, Analysis of interactions between the corneal epithelium and liposomes: Qualitative and quantitative fluorescence studies of a corneal epithelial cell line. Surv. Ophthalmol. 39, 3 (1995).
31. W. E. Magee, C. W. Goff, J. Schoknecht, M. D. Smith, and K. Cherian, The interaction of cationic liposomes containing entrapped horseradish peroxidase with cells in culture. J. Cell. Biol. 63, 492 (1974).
32. V. H. L. Lee, K. A. Takemoto, and D. S. Iimoto, Precorneal factors influencing the ocular distribution of topically applied inulin. Curr. Eye. Res. 3, 585 (1984).
33. H. E. Schaeffer, J. M. Brietfeller, and D. L. Krohn, Lectinmediated attachment of liposome to cornea: Influence on transcomeal drug flux. Invest. Ophth. 23, 530 (1983).
34. P. Fitzgerald, J. Hadgraft, and C. G. Wilson, A gamma scintigraphic evaluation of the precomeal residence of liposomal formulations in the rabbit. J. Pharm. Pharmacol. 39, 487 (1987).
35. V. K. Jansons, P. Weis, T. Chen, and W. R. Redwood, In vitro interaction of L 1210 cells with phospholipid vesicles. Cancer. Res. 38, 531 (1978).
36. D. Meisner, J. Pringle, and M. Mezei, Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine. Int. J. Pharm. 55, 105 (1989).
37. Y. Shen and J. Tu, Preparation and ocular pharmacokinetics of ganciclovir liposomes. AAPS. J. 9, E371 (2007).
38. H. M. Leibowitz and A. Kupferman, Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans. Am. Acad. Ophthalmol. Otolaryngol. 79, 78 (1975).
39. R. D. Schoenwald and R. L. Ward, Influence of high-viscosity vehicles on miotic effect of pilocarpine. J. Pharm. Sci. 67, 1280 (1978).
40. M. I. Afouna, I. S. Khattab, and I. K. Reddy, Preparation and characterization of demeclocycline liposomal formulations and assessment of their intraocular pressurelowering effects. Cutan. Ocul. Toxicol. 24, 111 (2005).
41. S. B. Kulkarni and E. I. Vargha-Butler, Study of liposomal drug delivery systems 2. Encapsulation efficiencies of some steroids in MLV liposomes. Colloid. Surface B 4, 77 (1995).
42. E. Mannermaa, K. Vellonen, and A. Urtti, Drug transport in corneal epithelium and blood-retina barrier: Emerging role of transporters in ocular pharmacokinetics. Adv. Drug. Deliver. Rev. 58, 1136 (2006).
43. J. B. Allen, T. Keng, and C. Privalle, Nitric oxide and peroxynitrite production in ocular inflammation. Environ. Health. Perspect. 106, 1145 (1998).